Written By: Satata Karmakar | Updated : December 8, 2023 3:05 PM IST
Image credits by: Painkiller Meftal Can Trigger Severe Adverse Reactions, Government Issues Alert
The Indian Pharmacopoeia Commission (IPC) on Thursday issued an alert regarding the use of a common painkiller, Meftal. In the warning statement, the officials stated that the pill has adverse reactions associated with its constituent, mefenamic acid. "Healthcare professionals, patients, and consumers are advised to closely monitor the possibility of the above adverse drug reactions (ADR) associated with the use of the above-suspected drug," the alert said.
Indian Pharmacopoeia Commission (IPC) issued a drug safety alert about Meftal painkiller, stating that its constituent, mefenamic acid, can cause adverse reactions pic.twitter.com/MHcfyoTLuI
ANI (@ANI) December 7, 2023
The commission, in its alert, said that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed DRESS syndrome. DRESS syndrome is a severe allergic reaction linked to certain medications, with symptoms such as skin rash, fever, and lymphadenopathy appearing between two and eight weeks after drug intake.
Meftal, a commonly used painkiller contains mefenamic acid, which is usually prescribed for various chronic conditions, including rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever, and dental pain.
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.
